Caribou Biosciences, Inc.

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead…

Biotechnology

US, Berkeley [HQ]

News

Theses · Events · Sentiments

Sentiments

25-01-14 -45.40%

NEW YORK , Jan. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Caribou Biosciences, Inc. ("Caribou Biosciences, …

25-01-13 0.60%

NEW YORK , Jan. 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Caribou …

25-01-10 -45.40%

NEW YORK , Jan. 10, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Caribou Biosciences, Inc. ("Caribou Biosciences, …

25-01-09 0.60%

NEW YORK , Jan. 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Caribou …

25-01-03 -45.40%

NEW YORK , Jan. 3, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Caribou Biosciences, Inc. ("Caribou Biosciences, …

25-01-02 -26.60%

NEW YORK, NY / ACCESSWIRE / January 2, 2025 / If you suffered a loss on your Caribou Biosciences, Inc. …

25-01-02 -26.60%

NEW YORK, NY / ACCESSWIRE / January 2, 2025 / If you suffered a loss on your Caribou Biosciences, Inc. …

24-12-31 -45.40%

NEW YORK , Dec. 31, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Caribou Biosciences, Inc. ("Caribou Biosciences, …